Haemonetics
HAE • NYSE
Haemonetics is a medical - instruments & supplies company in the healthcare sector trading on NYSE, led by CEO Christopher A. Simon, with a market cap of $2.5B.
CEOChristopher A. Simon
Next Earnings
Upcoming earnings announcement for Haemonetics
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q4 2026
EPS Estimate
$1.28
Revenue Estimate
$337.5M
Earnings History
Past 12 earnings reports for Haemonetics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 5, 2026 | Q3 2026 | $1.31Est: $1.26 | +4.0% | $339.0MEst: $333.3M | +1.7% |  10-Q |
| Nov 6, 2025 | Q2 2026 | $1.27Est: $1.11 | +14.4% | $327.3MEst: $311.3M | +5.1% | 10-Q |
| Aug 7, 2025 | Q1 2026 | $1.10Est: $1.01 | +8.9% | $321.4MEst: $304.1M | +5.7% | 10-Q |
| May 8, 2025 | Q4 2025 | $1.24Est: $1.22 | +1.6% | $331.0MEst: $329.4M | +0.5% | 10-K |
| Feb 6, 2025 | Q3 2025 | $1.19Est: $1.17 | +1.7% | $348.5MEst: $352.9M | -1.2% | 10-Q |
| Nov 7, 2024 | Q2 2025 | $1.12Est: $1.07 | +4.7% | $345.5MEst: $342.7M | +0.8% | 10-Q |
| Aug 8, 2024 | Q1 2025 | $1.02Est: $1.00 | +2.0% | $336.2MEst: $335.4M | +0.2% | 10-Q |
| May 9, 2024 | Q4 2024 | $0.90Est: $0.89 | +1.1% | $343.3MEst: $329.1M | +4.3% | 10-K |
| Feb 8, 2024 | Q3 2024 | $1.04Est: $0.94 | +10.6% | $336.3MEst: $320.3M | +5.0% | 10-Q |
| Nov 2, 2023 | Q2 2024 | $0.99Est: $0.89 | +11.2% | $318.2MEst: $313.1M | +1.6% | — |
| Aug 8, 2023 | Q1 2024 | $1.05Est: $0.76 | +38.2% | $311.3MEst: $297.9M | +4.5% | 10-Q |
| May 11, 2023 | Q4 2023 | $0.77Est: $0.70 | +10.0% | $304.4MEst: $289.6M | +5.1% | — |